Intuitive Surgical, Inc. $ISRG Stock: Formuepleje A S Raises Stake

Formuepleje A S grew its position in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG) by 41.8% during the third quarter, HoldingsChannel reports. The institutional investor owned 4,757 shares of the medical equipment provider’s stock after purchasing an additional 1,403 shares during the period. Formuepleje A S’s holdings in Intuitive Surgical were worth $1,934,000 as of its most recent SEC filing.

Other institutional investors have also recently made changes to their positions in the company. WealthPlan Investment Management LLC raised its stake in shares of Intuitive Surgical by 4.3% in the third quarter. WealthPlan Investment Management LLC now owns 5,122 shares of the medical equipment provider’s stock worth $2,083,000 after purchasing an additional 211 shares during the last quarter. Purus Wealth Management LLC boosted its position in shares of Intuitive Surgical by 0.8% during the third quarter. Purus Wealth Management LLC now owns 22,067 shares of the medical equipment provider’s stock valued at $8,973,000 after buying an additional 167 shares during the last quarter. Howard Financial Services LTD. boosted its position in shares of Intuitive Surgical by 23.9% during the third quarter. Howard Financial Services LTD. now owns 1,120 shares of the medical equipment provider’s stock valued at $455,000 after buying an additional 216 shares during the last quarter. William Allan Corp purchased a new stake in shares of Intuitive Surgical during the third quarter valued at $292,000. Finally, Hudock Inc. bought a new stake in Intuitive Surgical in the 3rd quarter worth about $207,000. Hedge funds and other institutional investors own 83.64% of the company’s stock.

Insider Buying and Selling

In other news, Director Gary S. Guthart sold 10,000 shares of the company’s stock in a transaction dated Tuesday, August 11th. The shares were sold at an average price of $400.00, for a total transaction of $4,000,000.00. Following the completion of the sale, the director owned 1,245,679 shares of the company’s stock, valued at $498,271,600. This represents a 0.80% decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Also, EVP Gary Loeb sold 400 shares of the stock in a transaction that occurred on Monday, August 10th. The stock was sold at an average price of $379.00, for a total transaction of $151,600.00. Following the completion of the transaction, the executive vice president owned 5,320 shares in the company, valued at $2,016,280. This trade represents a 6.99% decrease in their position. The disclosure for this sale is available in the SEC filing. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. Insiders have sold 12,370 shares of company stock valued at $4,891,989 in the last 90 days. Insiders own 0.60% of the company’s stock.

Analyst Ratings Changes

ISRG has been the subject of a number of recent analyst reports. JPMorgan Chase & Co. decreased their target price on Intuitive Surgical from $550.00 to $450.00 and set an “overweight” rating for the company in a research report on Friday, July 17th. Oppenheimer upgraded shares of Intuitive Surgical from a “market perform” rating to an “outperform” rating and set a $500.00 target price on the stock in a research note on Wednesday, August 12th. Raymond James Financial reaffirmed an “outperform” rating and set a $483.00 price target (down from $577.00) on shares of Intuitive Surgical in a report on Friday, July 17th. Leerink Partners reduced their price target on shares of Intuitive Surgical from $573.00 to $454.00 and set an “outperform” rating for the company in a research note on Friday, July 17th. Finally, HSBC cut shares of Intuitive Surgical from a “buy” rating to a “hold” rating and set a $391.00 price objective for the company. in a report on Thursday, July 30th. One analyst has rated the stock with a Strong Buy rating, twenty-two have issued a Buy rating, seven have assigned a Hold rating and one has given a Sell rating to the company. According to data from MarketBeat, Intuitive Surgical has a consensus rating of “Moderate Buy” and an average price target of $498.83.

Intuitive Surgical Stock Performance

Shares of ISRG stock traded up $5.12 on Thursday, reaching $425.36. The stock had a trading volume of 831,960 shares, compared to its average volume of 2,402,024. The stock has a market cap of $150.27 billion, a P/E ratio of 48.77, a price-to-earnings-growth ratio of 3.18 and a beta of 1.46. Intuitive Surgical, Inc. has a 1 year low of $328.57 and a 1 year high of $603.88. The company has a 50 day simple moving average of $389.39 and a 200 day simple moving average of $409.80.

Intuitive Surgical (NASDAQ:ISRG) last issued its quarterly earnings data on Thursday, July 16th. The medical equipment provider reported $2.80 EPS for the quarter, topping the consensus estimate of $2.48 by $0.32. The company had revenue of $2.89 billion during the quarter, compared to analyst estimates of $2.83 billion. Intuitive Surgical had a return on equity of 16.91% and a net margin of 28.45%. Intuitive Surgical’s revenue was up 18.4% compared to the same quarter last year. During the same quarter in the previous year, the company posted $1.81 earnings per share. On average, equities research analysts anticipate that Intuitive Surgical, Inc. will post 8.87 earnings per share for the current fiscal year.

About Intuitive Surgical

Intuitive Surgical, Inc develops and commercializes robotic-assisted systems and related technologies designed to support minimally invasive medical procedures. The company’s products are intended to help surgeons perform operations through small incisions while providing enhanced visualization, precision, and control.

Its principal product is the da Vinci Surgical System, a platform used across a range of specialties, including general surgery, urology, gynecology, thoracic surgery, and cardiac procedures.